MA
INSM icon

Montag & Associates’s Insmed INSM Stock Holding History

Montag & Associates’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.61K Hold
16
– – ﹤0.01% 827
2025
Q4 		$2.77K Sell
16
-2
-11% -$365 ﹤0.01% 845
2025
Q3 		$2.6K Sell
18
-500
-97% -$61.3K ﹤0.01% 889
2025
Q2 		$52.1K Buy
518
+1
+0.2% +$76 ﹤0.01% 580
2025
Q1 		$39.4K Buy
517
+17
+3% +$1.3K ﹤0.01% 653
2024
Q4 		$34.5K Hold
500
– – ﹤0.01% 658
2024
Q3 		$36.5K Sell
500
-131
-21% -$9.67K ﹤0.01% 650
2024
Q2 		$42.3K Buy
+631
New +$24.5K ﹤0.01% 616

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Montag & Associates's INSM Position: Q1 2026 in Review

Montag & Associates held its Insmed (INSM) position steady in Q1 2026 at 16 shares worth $2.61K. The position accounts for ﹤0.01% of the portfolio, ranked #827.

Montag & Associates first reported a position in INSM in Q2 2024 and has held it in 8 quarters since. The position peaked at $52.1K in Q2 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Montag & Associates held 16 shares of Insmed worth $2.61K as of Q1 2026.
  • Montag & Associates left its Insmed share count unchanged in Q1 2026.
  • Insmed made up ﹤0.01% of Montag & Associates's portfolio in Q1 2026, its #827 holding.
  • Montag & Associates first reported a position in Insmed in Q2 2024 and has held it in 8 quarters since.
  • Montag & Associates's Insmed position peaked at $52.1K in Q2 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.